LifePoint Health, Inc. (NASDAQ:LPNT) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday.

According to Zacks, “LifePoint Health’s stock has underperformed the industry in last one year. Following second-quarter results, the company trimmed its 2017 guidance on a challenging volume environment and weak revenue growth. The company is faced with increasing expenses which has outpaced revenue growth thereby squeezing operating margins. High bad debt is another concern. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2.9% downward over the last 30 daysThe stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2.9% downward over the last 30 days.”

A number of other research analysts also recently weighed in on LPNT. Morgan Stanley started coverage on LifePoint Health in a report on Tuesday, June 6th. They set an “equal weight” rating and a $65.00 target price on the stock. Leerink Swann upgraded LifePoint Health from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $73.00 to $74.00 in a report on Tuesday, June 6th. BidaskClub upgraded LifePoint Health from a “sell” rating to a “hold” rating in a report on Wednesday, June 14th. Royal Bank Of Canada reiterated a “buy” rating and set a $77.00 target price on shares of LifePoint Health in a report on Wednesday, July 5th. Finally, ValuEngine upgraded LifePoint Health from a “hold” rating to a “buy” rating in a report on Thursday, August 17th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $66.18.

Shares of LifePoint Health (LPNT) opened at 56.00 on Tuesday. The firm has a market cap of $2.25 billion, a PE ratio of 12.54 and a beta of 0.85. LifePoint Health has a 1-year low of $50.60 and a 1-year high of $70.95. The company’s 50-day moving average price is $59.01 and its 200 day moving average price is $62.36.

LifePoint Health (NASDAQ:LPNT) last posted its earnings results on Tuesday, August 1st. The company reported $0.96 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.06. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The firm had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the business earned $0.69 EPS. The business’s revenue for the quarter was up .2% on a year-over-year basis. On average, analysts predict that LifePoint Health will post $4.06 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This article was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/09/07/lifepoint-health-inc-lpnt-rating-lowered-to-sell-at-zacks-investment-research.html.

In other LifePoint Health news, Chairman William F. Carpenter III sold 82,347 shares of the firm’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $64.15, for a total value of $5,282,560.05. Following the completion of the sale, the chairman now owns 504,535 shares of the company’s stock, valued at $32,365,920.25. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Chairman William F. Carpenter III sold 17,653 shares of the firm’s stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the completion of the sale, the chairman now directly owns 439,841 shares of the company’s stock, valued at approximately $28,616,055.46. The disclosure for this sale can be found here. Company insiders own 7.28% of the company’s stock.

Several institutional investors have recently bought and sold shares of LPNT. BlackRock Inc. raised its stake in shares of LifePoint Health by 11,671.9% during the first quarter. BlackRock Inc. now owns 3,745,824 shares of the company’s stock valued at $245,351,000 after acquiring an additional 3,714,004 shares in the last quarter. LSV Asset Management raised its stake in shares of LifePoint Health by 83.5% during the second quarter. LSV Asset Management now owns 1,994,557 shares of the company’s stock valued at $133,934,000 after acquiring an additional 907,469 shares in the last quarter. Point72 Asset Management L.P. raised its stake in shares of LifePoint Health by 291.1% during the first quarter. Point72 Asset Management L.P. now owns 688,352 shares of the company’s stock valued at $45,087,000 after acquiring an additional 512,352 shares in the last quarter. Victory Capital Management Inc. raised its stake in shares of LifePoint Health by 130.6% during the second quarter. Victory Capital Management Inc. now owns 816,147 shares of the company’s stock valued at $54,804,000 after acquiring an additional 462,211 shares in the last quarter. Finally, Prudential Financial Inc. raised its stake in shares of LifePoint Health by 95.2% during the first quarter. Prudential Financial Inc. now owns 560,687 shares of the company’s stock valued at $36,725,000 after acquiring an additional 273,445 shares in the last quarter. 99.53% of the stock is owned by hedge funds and other institutional investors.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Stock Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related stocks with our FREE daily email newsletter.